Results 11 to 20 of about 2,126,593 (244)

Macrophages and Autoantibodies in Demyelinating Diseases

Cells, 2021
Myelin phagocytosis by macrophages has been an essential feature of demyelinating diseases in the central and peripheral nervous systems, including Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multiple ...
Haruki Koike, Masahisa Katsuno
doaj   +2 more sources

Peripheral Demyelinating Diseases: From Biology to Translational Medicine [PDF]

Frontiers in Neurology, 2019
Demyelinating diseases represent a spectrum of disorders that impose significant burden on global economy and society. Generally, the prognosis of these diseases is poor and there is no available cure.
Khidhir Kamil, Muhammad Dain Yazid, Ruszymah Bt Hj Idrus, Srijit Das, Jaya Kumar   +4 more
doaj   +2 more sources

Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases

Cancer Medicine, 2023
Background Distinguishing between central nervous system lymphoma (CNSL) and CNS infectious and/or demyelinating diseases, although clinically important, is sometimes difficult even using imaging strategies and conventional cerebrospinal fluid (CSF ...
Chisako Iriyama, Kenichiro Murate, Sachiko Iba, Akinao Okamoto, Naoe Goto, Hideyuki Yamamoto, Toshiharu Kato, Keichiro Mihara, Takahiko Miyama, Keiko Hattori, Ryoko Kajiya, Masataka Okamoto, Yasuaki Mizutani, Seiji Yamada, Tetsuya Tsukamoto, Yuichi Hirose, Tatsuro Mutoh, Hirohisa Watanabe, Akihiro Tomita   +18 more
doaj   +2 more sources

Pregnancy-Related Immune Changes and Demyelinating Diseases of the Central Nervous System

Frontiers in Neurology, 2019
Demyelinating diseases of the central nervous system comprise a heterogeneous group of autoimmune disorders characterized by myelin loss with relative sparing of axons occurring on a background of inflammation.
Ke Qiu, Qiang He, Xiqian Chen, Hui Liu, Shuwen Deng, Wei Lu   +5 more
doaj   +3 more sources

Bibliometric analysis of the intestinal microbiota and demyelinating diseases, particularly multiple sclerosis, since 2014

Frontiers in Neuroscience
BackgroundThe gut–brain axis (GBA) represents a complex, bidirectional communication network that connects the central nervous system (CNS) and the gastrointestinal system.
Ling Chen, Le-Le Wu, Chang-Yin Yu, Zu-Cai Xu, Hao Huang   +4 more
doaj   +3 more sources

Brainstem syndrome at onset is related to an early MS diagnosis in Peru: A national referral center cohort

Heliyon, 2021
Background: MS is unpredictable regarding clinical symptoms; however, certain symptoms represent the preferred localization of white matter lesions such as brainstem, spinal cord; or optic nerve.
César Caparó-Zamalloa, Sheila Castro-Suarez, Jaqueline Cortez-Escalante, Wilfor Aguirre-Quispe, Erik Guevara-Silva, Victor Osorio-Marcatinco, María Meza-Vega   +6 more
doaj   +1 more source

Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options [PDF]

Clinical and Experimental Pediatrics, 2021
Inflammatory or immune-mediated demyelinating central nervous system (CNS) syndromes include a broad spectrum of clinical phenotype and different overlapping diseases.
Yun-Jin Lee, Sang Ook Nam, Ara Ko, JuHyun Kong, Shin Yun Byun   +4 more
doaj   +1 more source

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases

Frontiers in Neurology, 2022
Tumefactive demyelinating lesions (TDL) represent a diagnostic dilemma for clinicians, and in rare atypical cases a collaboration of a neuroradiologist, a neurologist, and a neuropathologist is warranted for accurate diagnosis.
Aigli G. Vakrakou, Maria-Evgenia Brinia, Ioanna Svolaki, Theodore Argyrakos, Leonidas Stefanis, Constantinos Kilidireas   +5 more
doaj   +1 more source

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs

Clinical Immunology Communications, 2023
We analyzed immune response to SARS-CoV-2 vaccination by measuring specific IgG titers and T-cell reactivity to different SARS-CoV-2 peptides in multiple sclerosis patients taking different disease-modifying treatments.
Virginia Meca-Lallana, Laura Esparcia-Pinedo, Clara Aguirre, Carolina Díaz-Pérez, Ainhoa Gutierrez-Cobos, Mónica Sobrado, Estefanía Carabajal, Beatriz del Río, Noelia Ropero, Ramón Villagrasa, José Vivancos, Francisco Sanchez-Madrid, Arantzazu Alfranca   +12 more
doaj   +1 more source

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature

Frontiers in Neurology, 2020
Atypical forms of demyelinating diseases with tumor-like lesions and aggressive course represent a diagnostic and therapeutic challenge for neurologists.
Aigli G. Vakrakou, Dimitrios Tzanetakos, Theodore Argyrakos, Georgios Koutsis, Maria-Eleptheria Evangelopoulos, Elisabeth Andreadou, Maria Anagnostouli, Marianthi Breza, John S. Tzartos, Elias Gialafos, Antonios N. Dimitrakopoulos, Georgios Velonakis, Panagiotis Toulas, Leonidas Stefanis, Constantinos Kilidireas   +14 more
doaj   +1 more source